ArticleCellular and molecular life sciences : CMLS2025
Transcriptome remodelling and changes in growth and cardiometabolic phenotype result following Grb10a knockdown in the early life of the zebrafish.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Embryonic growth trajectory is a risk factor for chronic metabolic and cardiovascular disorders. Grb10 is a negative regulator of the main pathways driving embryonic growth. This study has characterised growth, cardiometabolic status, and the impact on co-ordination of gene expression following morpholino-induced embryonic and early larval knockdown (KD) of grb10a expression in zebrafish (Danio rerio). Grb10 knockdown was associated with increased embryonic growth and metabolic rate, and decreased heart rate in early life. Juvenile growth rate was also elevated. The transcriptome was assessed over 5 to 30 days post fertilisation, coinciding with major changes in zebrafish (ZF) maturation and development. Significant and persistent organisational and functional changes in the whole transcriptome over this time were evident, including dysregulation of multiple growth, cardiac, and metabolic pathways. In adulthood (18 months), KD ZF had greater body length and mass than controls, with elevated cardiac muscle content, an increased aerobic scope, and higher fasting glucose levels. This study demonstrates that early life disruption of a single gene in zebrafish can result in long-term transcriptomic remodelling and alterations to the adult cardiometabolic phenotype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.